Efficacy and Safety of Sarilumab for Noninfectious Uveitis of Posterior Segment: Outcomes From the Phase 2 SATURN Trial.

Jarmila Heissigerová,David Callanan,Marc D de Smet,Sunil K Srivastava, Michala Karkanová,Olga Garcia-Garcia,Sibel Kadayifcilar,Yilmaz Ozyazgan,Robert Vitti,Kristine Erickson,Aditya Athanikar,Karen Chu,Namrata Saroj,Preethi A Sundaram,Rafael Varona,Valerie Corp-Dit-Genti,Ronald Buggage,Yenchieh Cheng,Yuhwen Soo,Quan Dong Nguyen

Ophthalmology（2019）

引用 41|浏览28

暂无评分

摘要

Subcutaneous sarilumab may provide clinical benefits in the management of NIU of the posterior segment, especially in eyes with uveitic macular edema.

查看译文

关键词

AE,BCVA,CST,IL,NIU,RA,SATURN,SC,VH

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要